biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > As always, nothing going on

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on Dec 13, 2021 12:42pm

126 Views

Post# 34225490

RE:RE:As always, nothing going on

LOL, yeah, I don't understand business but this is coming from someone who has been invested in a company for well over 10+ years where they have accomplished next to nothing. Of course for the last 10+ year, you have been saying the same things over and over yet none of it has come to fruition. So go ahead and gloat, i just have no idea what you're gloating about

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season